Cohen Capital Management, Inc. Oncternal Therapeutics, Inc. Transaction History

Cohen Capital Management, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2020 Feb 03, 2021	SELL	$1.51 - $6.3 $19,699 - $82,189	-13,046 Closed	0 $0
Q2 2019 Aug 07, 2019	BUY	$4.86 - $9.24 $63,403 - $120,545	13,046 New	13,046 $87,000

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $223M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of Cohen Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Cohen Capital Management, Inc. with notifications on news.